Social Capital

PureTech Founded Entity Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I

Retrieved on: 
Tuesday, February 15, 2022
Health, Technology, Other Technology, Other Health, General Health, Clinical Trials, Biotechnology, Adoption, LSE, Prospectus, XV, Private Securities Litigation Reform Act, Therapy, Technology, Suite, U.S. Securities and Exchange Commission, Government budget balance, Acquisition, U.S. FDA, Entrepreneurship, COVID-19, PALO, Mergers and acquisitions, Company, PRTC, Tripura Merger Agreement, SEC, Xi, Registration statement, Securities Act of 1933, Vii, SCS, Twitter, Degenerative disease, Sale, Research, 100,000, Industry, Connection, Social capital, ALL, Risk, Brain, Capitalism, Nasdaq, THE, Register, PureTech Health, Name, Cancer, Communication, Medicine, Form, Business architecture, Forward-looking statement, Annual report, Environment, Proxy, Biology, FDA, Axis, Failure, BIG, Online gambling, Audit, Security (finance), Property management, Risk management, Yolo Akili, Akili, Social Capital, Social Capital Suvretta Holdings Corp I, PureTech Health, AKILI, SOCIAL CAPITAL, SOCIAL CAPITAL SUVRETTA HOLDINGS CORP I, PURETECH HEALTH

The full text of the announcement from Akili is as follows:

Key Points: 
  • The full text of the announcement from Akili is as follows:
    Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp.
  • and PALO ALTO, Calif. February 14, 2022 Akili Interactive (Akili or the Company), a leading digital medicine company developing cognitive treatments through game-changing technologies, announced that Social Capital Suvretta Holdings Corp.
  • I (SCS) (Nasdaq: DNAA) has filed with the U.S. Securities and Exchange Commission (SEC) a registration statement on Form S-4 (the Registration Statement), which contains a preliminary proxy statement/prospectus, in connection with the previously announced proposed business combination with Akili.
  • While the Registration Statement has not yet become effective and the information contained therein is subject to change, it provides important information about Akili and the proposed business combination with SCS.

Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I

Retrieved on: 
Monday, February 14, 2022
Health, Technology, Mobile, Wireless, Clinical Trials, General Health, Biotechnology, Social capital, Mergers and acquisitions, Adoption, Form, Prospectus, ALL, Risk, Registration statement, Tripura Merger Agreement, Brain, SEC, Forward-looking statement, Xi, XV, Capitalism, Nasdaq, THE, Register, Technology, Proxy, Suite, Vii, U.S. Securities and Exchange Commission, Name, SCS, Securities Act of 1933, Government budget balance, Sale, Communication, Acquisition, Failure, Industry, Entrepreneurship, Research, 100,000, COVID-19, Medicine, Online gambling, Property management, Yolo Akili, Akili, Social Capital, Social Capital Suvretta Holdings Corp I, AKILI, SOCIAL CAPITAL, SOCIAL CAPITAL SUVRETTA HOLDINGS CORP I

Akili Interactive (Akili or the Company), a leading digital medicine company developing cognitive treatments through game-changing technologies, announced that Social Capital Suvretta Holdings Corp.

Key Points: 
  • Akili Interactive (Akili or the Company), a leading digital medicine company developing cognitive treatments through game-changing technologies, announced that Social Capital Suvretta Holdings Corp.
  • I (SCS) (Nasdaq: DNAA) has filed with the U.S. Securities and Exchange Commission (SEC) a registration statement on Form S-4 (the Registration Statement), which contains a preliminary proxy statement/prospectus, in connection with the previously announced proposed business combination with Akili.
  • While the Registration Statement has not yet become effective and the information contained therein is subject to change, it provides important information about Akili and the proposed business combination with SCS.
  • Neither Akili nor SCS gives any assurance that either Akili or SCS, or the combined company, will achieve its expectations.

Perimeter Medical Imaging AI Announces Closing of Strategic Private Placement to Social Capital

Retrieved on: 
Thursday, January 27, 2022
Health, Surgery, Oncology, Medical Devices, SEDAR, Multilateral, Legislation, Ownership, Breast Cancer Awareness Month, Investment, Surgeon, Exercise, Indian stock exchange, Public expenditure, Risk, Acquisition, Private, Patient, Knowledge, News, S series, Related, Research, Growth, Business development, Company, Sale, Female, National instrument, CEO, Medical imaging, Private placement, OTC, Disclosure, TSX Venture Exchange, Suite, Minority, MI, Capitalism, Breast cancer, Marie Cassidy, Technology, Time, Analysis, Forward-looking statement, Perimeter, Entrepreneurship, Social, Radiology, Social capital, Cancer, Awareness, Partnership, Tax, 3D printing, Security (finance), Life insurance, Unit, Warrant, Social Capital, Perimeter Medical Imaging AI, Inc., SOCIAL CAPITAL, PERIMETER MEDICAL IMAGING AI, INC.

Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (Perimeter or the Company), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, is pleased to announce the closing of its previously announced private placement of units (each, a Unit) for gross proceeds of C$48.7 million to the Company (the Private Placement).

Key Points: 
  • Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (Perimeter or the Company), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, is pleased to announce the closing of its previously announced private placement of units (each, a Unit) for gross proceeds of C$48.7 million to the Company (the Private Placement).
  • The Private Placement included the C$43.4 million strategic investment in the Company (the Investment) by Social Capital.
  • Subject to the accelerated expiry clause described above, all Warrants will expire five years following the closing of the Private Placement.
  • About Perimeter Medical Imaging AI, Inc.
    With headquarters in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) is a medical technology company that is driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need.

Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I

Retrieved on: 
Wednesday, January 26, 2022
Technology, Mobile, Wireless, Venture Capital, Other Technology, Professional Services, Biotechnology, Other Health, Health, Pharmaceutical, Akili, Social Capital, Social Capital Suvretta Holdings Corp I, AKILI, SOCIAL CAPITAL, SOCIAL CAPITAL SUVRETTA HOLDINGS CORP I

Akili Interactive (Akili or the Company), a leading digital medicine company developing cognitive treatments through game-changing technologies, has entered into a definitive agreement to become publicly traded via a merger with Social Capital Suvretta Holdings Corp.

Key Points: 
  • Akili Interactive (Akili or the Company), a leading digital medicine company developing cognitive treatments through game-changing technologies, has entered into a definitive agreement to become publicly traded via a merger with Social Capital Suvretta Holdings Corp.
  • This core platform has the potential to be applied across a diverse set of indications within psychiatry and neurology.
  • With its first-ever, clinically validated digital therapeutic (EndeavorRx), Akili has the unique opportunity to change how we treat pediatric ADHD.
  • Neither Akili nor SCS gives any assurance that either Akili or SCS, or the combined company, will achieve its expectations.

PureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I

Retrieved on: 
Wednesday, January 26, 2022
Health, FDA, Other Health, General Health, Clinical Trials, Pharmaceutical, Biotechnology, Akili, Social Capital, Social Capital Suvretta Holdings Corp I, PureTech Health, AKILI, SOCIAL CAPITAL, SOCIAL CAPITAL SUVRETTA HOLDINGS CORP I, PURETECH HEALTH

The full text of the announcement from Akili is as follows:

Key Points: 
  • The full text of the announcement from Akili is as follows:
    Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp.
  • Specifically, current treatment options are designed to focus on symptoms and coping strategies instead of directly targeting cognitive functioning.
  • These therapeutic shortfalls are especially concerning for younger populations who are potentially facing a lifetime of managing these conditions.
  • With its first-ever, clinically validated digital therapeutic (EndeavorRx), Akili has the unique opportunity to change how we treat pediatric ADHD.

Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to Become Publicly Traded via Business Combination with Social Capital Suvretta Holdings Corp. III

Retrieved on: 
Tuesday, January 18, 2022
Biotechnology, Infectious Diseases, Health, Pharmaceutical, Clinical Trials, ProKidney, Social Capital, Social Capital Suvretta Holdings Corp. III, PROKIDNEY, SOCIAL CAPITAL, SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III

ProKidney LP (ProKidney), a leading clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), has entered into a definitive agreement to become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III (SCS) (Nasdaq: DNAC), a special purpose acquisition company.

Key Points: 
  • ProKidney LP (ProKidney), a leading clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), has entered into a definitive agreement to become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III (SCS) (Nasdaq: DNAC), a special purpose acquisition company.
  • If left untreated, many CKD patients progress to end-stage renal disease (ESRD) or kidney failure and require dialysis or kidney transplant.
  • The Phase 3 program,initiated in January 2022, may enroll up to 1,500 participants withprimary analysis projected to occur in 2025.
  • Neither ProKidney nor SCS gives any assurance that either ProKidney or SCS, or the combined company, will achieve its expectations.

Perimeter Medical Imaging AI Announces Strategic Private Placement to Social Capital

Retrieved on: 
Wednesday, December 15, 2021
Technology, Surgery, Medical Devices, Audio, Video, Software, Biotechnology, Hardware, Health, Oncology, Forward-looking statement, Social capital, OTC, Marie Cassidy, Company, Capitalism, Medical imaging, Growth, SEDAR, Sale, Public expenditure, Breast cancer, Female, Breast Cancer Awareness Month, Time, Social, AI, Private, CEO, Research, Awareness, Private placement agent, Radiology, Indian stock exchange, Warrant, TSX Venture Exchange, Surgeon, Private placement, Legislation, TSX, Analysis, Tax, News, Technology, Entrepreneurship, S series, Security (finance), Unit, Perimeter, the Investment, Social Capital, Perimeter Medical Imaging AI, Inc., THE INVESTMENT, SOCIAL CAPITAL, PERIMETER MEDICAL IMAGING AI, INC.

Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (Perimeter or the Company), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, today announced that it has entered into a subscription agreement pursuant to which an affiliate of Social Capital Holdings Inc. (Social Capital) will make a strategic C$43.4 million investment in the Company.

Key Points: 
  • Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (Perimeter or the Company), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, today announced that it has entered into a subscription agreement pursuant to which an affiliate of Social Capital Holdings Inc. (Social Capital) will make a strategic C$43.4 million investment in the Company.
  • Chamath Palihapitiya, CEO of Social Capital, said, Perimeters advanced imaging technology has the opportunity to materially improve cancer surgery outcomes.
  • Social Capital will also enter into an investor rights agreement with Perimeter at the closing of the Private Placement, which will provide Social Capital with the right to nominate one director to the board of Perimeter, with anti-dilution rights to participate in future financings, and with customary registration rights.
  • About Perimeter Medical Imaging AI, Inc.
    With headquarters in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) is a medical technology company that is driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need.

Maryland Innovation Center welcomes Social Capital Builders

Retrieved on: 
Monday, August 2, 2021
Academic disciplines, Articles, Capital, Economic sociology, Social Capital, Social economy, Socioeconomics, Literacy

DeJesus Solutions' Social Capital Builders project works to advance the lifelong economic and social well-being of youth through social capital literacy, analysis and development.

Key Points: 
  • DeJesus Solutions' Social Capital Builders project works to advance the lifelong economic and social well-being of youth through social capital literacy, analysis and development.
  • DeJesus knows the pivotal role social capital plays in helping individuals connect to and excel in, careers and life.
  • With the help of the company's CTO, Adam Douglas, Social Capital Builders is ready to launch their Foundations in Social Capital Literacy curriculum and web-based application this fall.
  • Chuck Bubeck, the Executive Director of the Innovation Center stated, "We are excited to house this important project at MIC and look forward to supporting Social Capital Builders as they build momentum for youth to build economic and social wellbeing."

National "Give Something Away Day" Strengthens Relationship, Happiness

Retrieved on: 
Thursday, July 15, 2021
Articles, Emotions, Self, Personal life, Positive mental attitude, Happiness, Philosophy of love, Pleasure, Uptick rule, Ethics

SALT LAKE CITY, July 15, 2021 /PRNewswire/ -- Celebrating the annual national "Give Something Away Day" on July 15 strengthens relationships, increases happiness and causes a contagious uptick in kindness, according to one CEO responsible for providing millions of meals to impoverished children.

Key Points: 
  • SALT LAKE CITY, July 15, 2021 /PRNewswire/ -- Celebrating the annual national "Give Something Away Day" on July 15 strengthens relationships, increases happiness and causes a contagious uptick in kindness, according to one CEO responsible for providing millions of meals to impoverished children.
  • "I see no downside to giving something away to make a difference in the lives of others."
  • Studies show once we have enough income to comfortably meet basic needs, additional wealth has little impact on our happiness.
  • This year, Guest urges others to give something away and find harmony, happiness and peace.

The Impact Genome Project® and MassMutual Foundation Announce New Research Measuring Social Capital – particularly critical in post-pandemic America

Retrieved on: 
Monday, June 14, 2021
Public policy, Government, Finance, Labor, Professional services, Philanthropy, Consumer, Other Consumer, Foundation, Academic disciplines, Genomics, Jason Saul, Subfields of sociology, Social Capital, MassMutual, Genome project, Genome, The Impact Genome Project®, the MassMutual Foundation, THE IMPACT GENOME PROJECT®, THE MASSMUTUAL FOUNDATION

New research from The Impact Genome Project and the MassMutual Foundation finds marginalized populations face barriers to higher paying jobs, healthcare, and financial stability.

Key Points: 
  • New research from The Impact Genome Project and the MassMutual Foundation finds marginalized populations face barriers to higher paying jobs, healthcare, and financial stability.
  • Most recently, this includes identifying the need to better understand what it takes to build Social Capital and funding the Social Capital Genome.
  • Jason Saul, CEO of The Impact Genome Project and Dennis Duquette, President of the MassMutual Foundation, will convene for a live briefing, State of Impact: Social Capital, on Tuesday, June 29 at 3 p.m.
  • Read more about the Social Capital Genome in our White Paper: Cracking the Code on Social Capital, What Works & Why
    The Impact Genome Project uses precision data to solve the worlds most intractable social problems, including financial stability, employment, food security, housing, social capital and education.